Group VIA Phospholipase A2 Mediates Enhanced Macrophage Migration in Diabetes Mellitus by Increasing Expression of Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4

OBJECTIVE—We previously demonstrated that nicotinamide adenine dinucleotide phosphate oxidase 4 (Nox4) mediates increased monocyte priming and chemotaxis under conditions of diabetic metabolic stress, and emerging data indicate that group VIA phospholipase A2 (iPLA2β) also participates in regulating...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2014-04, Vol.34 (4), p.768-778
Hauptverfasser: Tan, Chunyan, Day, Robert, Bao, Shunzhong, Turk, John, Zhao, Qingwei David
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 778
container_issue 4
container_start_page 768
container_title Arteriosclerosis, thrombosis, and vascular biology
container_volume 34
creator Tan, Chunyan
Day, Robert
Bao, Shunzhong
Turk, John
Zhao, Qingwei David
description OBJECTIVE—We previously demonstrated that nicotinamide adenine dinucleotide phosphate oxidase 4 (Nox4) mediates increased monocyte priming and chemotaxis under conditions of diabetic metabolic stress, and emerging data indicate that group VIA phospholipase A2 (iPLA2β) also participates in regulating monocyte chemotaxis. Here, we examined relationships between iPLA2β expression and Nox4 action in mouse peritoneal macrophages subjected to diabetic metabolic stress. APPROACH AND RESULTS—Increased iPLA2β expression and activity were observed in macrophages from low-density lipoprotein receptor knockout mice that were fed a high-fat diet, and this was associated with time-dependent increases in atherosclerotic lesion size and macrophage content. Incubating macrophages with 30 mmol/L D-glucose, 100 μg/mL low-density lipoprotein, or both (D-glucose+low-density lipoprotein) induced a robust increase in iPLA2β expression and activity and in cell migration in response to monocyte chemoattractant protein-1. The increases in iPLA2β activity and cell migration were prevented by a bromoenol lactone iPLA2β suicide inhibitor or an iPLA2β antisense oligonucleotide. Incubating macrophages under conditions that mimic diabetic metabolic stress ex vivo resulted in increased Nox4 expression and activity and hydrogen peroxide generation compared with controls. Bromoenol lactone prevented those effects without affecting Nox2 expression. Nox4 inhibition eliminated diabetic metabolic stress–induced acceleration of macrophage migration. Lysophosphatidic acid restored Nox4 expression, hydrogen peroxide generation, and migration to bromoenol lactone–treated cells, and a lysophosphatidic acid receptor antagonist abrogated iPLA2β-mediated increases in Nox4 expression. CONCLUSIONS—Taken together, these observations identify iPLA2β and lysophosphatidic acid derived from its action as critical in regulating macrophage Nox4 activity and migration in the diabetic state in vivo and under similar conditions ex vivo.
doi_str_mv 10.1161/ATVBAHA.113.302847
format Article
fullrecord <record><control><sourceid>pubmed_wolte</sourceid><recordid>TN_cdi_pubmed_primary_24482376</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>24482376</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1713-3738729a0aa02e12c2f0417bdae105d417bec6e88752d9bd2033faab0ae8528d3</originalsourceid><addsrcrecordid>eNo1kEtOw0AMhkcIRKFwARZoLhCYVx5dBihtpRZYQLeVk3GbgXQSzSQCbsQxmaiwsOzf_mT_MiFXnN1wnvDb_HV9l8_zIOSNZCJT6RE547FQkUpkchxqlk6iOFFiRM69f2eMKSHYKRkJpTIh0-SM_Mxc07d0vcjpS9X4tmpq04JHmgu6Qm2gQ0-ntgJboqYrKF3TVrBDujI7B51pLDWWPhgocCBXWNem6z0tvunClg7BG7uj06_WofcD3WzpkymbzljYGx3uaLTGYlhh-7LGMAjNg5Vwmz5_GT3YURfkZAu1x8u_PCZvj9PX-3m0fJ4t7vNl1PKUy0imMkvFBBgAE8hFKbZM8bTQgJzFeiixTDDL0ljoSaEFk3ILUDDALBaZlmNyfdjb9sUe9aZ1Zg_ue_P_sgCoA_DZ1B06_1H3n-g2FULdVZvhxzJhcSQYV0wFGYXgUv4Cb1OAzw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Group VIA Phospholipase A2 Mediates Enhanced Macrophage Migration in Diabetes Mellitus by Increasing Expression of Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Tan, Chunyan ; Day, Robert ; Bao, Shunzhong ; Turk, John ; Zhao, Qingwei David</creator><creatorcontrib>Tan, Chunyan ; Day, Robert ; Bao, Shunzhong ; Turk, John ; Zhao, Qingwei David</creatorcontrib><description>OBJECTIVE—We previously demonstrated that nicotinamide adenine dinucleotide phosphate oxidase 4 (Nox4) mediates increased monocyte priming and chemotaxis under conditions of diabetic metabolic stress, and emerging data indicate that group VIA phospholipase A2 (iPLA2β) also participates in regulating monocyte chemotaxis. Here, we examined relationships between iPLA2β expression and Nox4 action in mouse peritoneal macrophages subjected to diabetic metabolic stress. APPROACH AND RESULTS—Increased iPLA2β expression and activity were observed in macrophages from low-density lipoprotein receptor knockout mice that were fed a high-fat diet, and this was associated with time-dependent increases in atherosclerotic lesion size and macrophage content. Incubating macrophages with 30 mmol/L D-glucose, 100 μg/mL low-density lipoprotein, or both (D-glucose+low-density lipoprotein) induced a robust increase in iPLA2β expression and activity and in cell migration in response to monocyte chemoattractant protein-1. The increases in iPLA2β activity and cell migration were prevented by a bromoenol lactone iPLA2β suicide inhibitor or an iPLA2β antisense oligonucleotide. Incubating macrophages under conditions that mimic diabetic metabolic stress ex vivo resulted in increased Nox4 expression and activity and hydrogen peroxide generation compared with controls. Bromoenol lactone prevented those effects without affecting Nox2 expression. Nox4 inhibition eliminated diabetic metabolic stress–induced acceleration of macrophage migration. Lysophosphatidic acid restored Nox4 expression, hydrogen peroxide generation, and migration to bromoenol lactone–treated cells, and a lysophosphatidic acid receptor antagonist abrogated iPLA2β-mediated increases in Nox4 expression. CONCLUSIONS—Taken together, these observations identify iPLA2β and lysophosphatidic acid derived from its action as critical in regulating macrophage Nox4 activity and migration in the diabetic state in vivo and under similar conditions ex vivo.</description><identifier>ISSN: 1079-5642</identifier><identifier>EISSN: 1524-4636</identifier><identifier>DOI: 10.1161/ATVBAHA.113.302847</identifier><identifier>PMID: 24482376</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject>Animals ; Atherosclerosis - enzymology ; Atherosclerosis - genetics ; Atherosclerosis - immunology ; Atherosclerosis - pathology ; Cell Movement ; Cells, Cultured ; Diabetes Mellitus - enzymology ; Diabetes Mellitus - genetics ; Diabetes Mellitus - immunology ; Diabetes Mellitus - pathology ; Diet, High-Fat ; Disease Models, Animal ; Disease Progression ; Enzyme Inhibitors - pharmacology ; Group VI Phospholipases A2 - genetics ; Group VI Phospholipases A2 - metabolism ; Hydrogen Peroxide - metabolism ; Lysophospholipids - metabolism ; Macrophages, Peritoneal - enzymology ; Macrophages, Peritoneal - immunology ; Macrophages, Peritoneal - pathology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; NADPH Oxidase 4 ; NADPH Oxidases - genetics ; NADPH Oxidases - metabolism ; Oligonucleotides, Antisense - metabolism ; Receptors, LDL - deficiency ; Receptors, LDL - genetics ; Signal Transduction ; Stress, Physiological ; Time Factors ; Transfection ; Up-Regulation</subject><ispartof>Arteriosclerosis, thrombosis, and vascular biology, 2014-04, Vol.34 (4), p.768-778</ispartof><rights>2014 American Heart Association, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24482376$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tan, Chunyan</creatorcontrib><creatorcontrib>Day, Robert</creatorcontrib><creatorcontrib>Bao, Shunzhong</creatorcontrib><creatorcontrib>Turk, John</creatorcontrib><creatorcontrib>Zhao, Qingwei David</creatorcontrib><title>Group VIA Phospholipase A2 Mediates Enhanced Macrophage Migration in Diabetes Mellitus by Increasing Expression of Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4</title><title>Arteriosclerosis, thrombosis, and vascular biology</title><addtitle>Arterioscler Thromb Vasc Biol</addtitle><description>OBJECTIVE—We previously demonstrated that nicotinamide adenine dinucleotide phosphate oxidase 4 (Nox4) mediates increased monocyte priming and chemotaxis under conditions of diabetic metabolic stress, and emerging data indicate that group VIA phospholipase A2 (iPLA2β) also participates in regulating monocyte chemotaxis. Here, we examined relationships between iPLA2β expression and Nox4 action in mouse peritoneal macrophages subjected to diabetic metabolic stress. APPROACH AND RESULTS—Increased iPLA2β expression and activity were observed in macrophages from low-density lipoprotein receptor knockout mice that were fed a high-fat diet, and this was associated with time-dependent increases in atherosclerotic lesion size and macrophage content. Incubating macrophages with 30 mmol/L D-glucose, 100 μg/mL low-density lipoprotein, or both (D-glucose+low-density lipoprotein) induced a robust increase in iPLA2β expression and activity and in cell migration in response to monocyte chemoattractant protein-1. The increases in iPLA2β activity and cell migration were prevented by a bromoenol lactone iPLA2β suicide inhibitor or an iPLA2β antisense oligonucleotide. Incubating macrophages under conditions that mimic diabetic metabolic stress ex vivo resulted in increased Nox4 expression and activity and hydrogen peroxide generation compared with controls. Bromoenol lactone prevented those effects without affecting Nox2 expression. Nox4 inhibition eliminated diabetic metabolic stress–induced acceleration of macrophage migration. Lysophosphatidic acid restored Nox4 expression, hydrogen peroxide generation, and migration to bromoenol lactone–treated cells, and a lysophosphatidic acid receptor antagonist abrogated iPLA2β-mediated increases in Nox4 expression. CONCLUSIONS—Taken together, these observations identify iPLA2β and lysophosphatidic acid derived from its action as critical in regulating macrophage Nox4 activity and migration in the diabetic state in vivo and under similar conditions ex vivo.</description><subject>Animals</subject><subject>Atherosclerosis - enzymology</subject><subject>Atherosclerosis - genetics</subject><subject>Atherosclerosis - immunology</subject><subject>Atherosclerosis - pathology</subject><subject>Cell Movement</subject><subject>Cells, Cultured</subject><subject>Diabetes Mellitus - enzymology</subject><subject>Diabetes Mellitus - genetics</subject><subject>Diabetes Mellitus - immunology</subject><subject>Diabetes Mellitus - pathology</subject><subject>Diet, High-Fat</subject><subject>Disease Models, Animal</subject><subject>Disease Progression</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Group VI Phospholipases A2 - genetics</subject><subject>Group VI Phospholipases A2 - metabolism</subject><subject>Hydrogen Peroxide - metabolism</subject><subject>Lysophospholipids - metabolism</subject><subject>Macrophages, Peritoneal - enzymology</subject><subject>Macrophages, Peritoneal - immunology</subject><subject>Macrophages, Peritoneal - pathology</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>NADPH Oxidase 4</subject><subject>NADPH Oxidases - genetics</subject><subject>NADPH Oxidases - metabolism</subject><subject>Oligonucleotides, Antisense - metabolism</subject><subject>Receptors, LDL - deficiency</subject><subject>Receptors, LDL - genetics</subject><subject>Signal Transduction</subject><subject>Stress, Physiological</subject><subject>Time Factors</subject><subject>Transfection</subject><subject>Up-Regulation</subject><issn>1079-5642</issn><issn>1524-4636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kEtOw0AMhkcIRKFwARZoLhCYVx5dBihtpRZYQLeVk3GbgXQSzSQCbsQxmaiwsOzf_mT_MiFXnN1wnvDb_HV9l8_zIOSNZCJT6RE547FQkUpkchxqlk6iOFFiRM69f2eMKSHYKRkJpTIh0-SM_Mxc07d0vcjpS9X4tmpq04JHmgu6Qm2gQ0-ntgJboqYrKF3TVrBDujI7B51pLDWWPhgocCBXWNem6z0tvunClg7BG7uj06_WofcD3WzpkymbzljYGx3uaLTGYlhh-7LGMAjNg5Vwmz5_GT3YURfkZAu1x8u_PCZvj9PX-3m0fJ4t7vNl1PKUy0imMkvFBBgAE8hFKbZM8bTQgJzFeiixTDDL0ljoSaEFk3ILUDDALBaZlmNyfdjb9sUe9aZ1Zg_ue_P_sgCoA_DZ1B06_1H3n-g2FULdVZvhxzJhcSQYV0wFGYXgUv4Cb1OAzw</recordid><startdate>201404</startdate><enddate>201404</enddate><creator>Tan, Chunyan</creator><creator>Day, Robert</creator><creator>Bao, Shunzhong</creator><creator>Turk, John</creator><creator>Zhao, Qingwei David</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>201404</creationdate><title>Group VIA Phospholipase A2 Mediates Enhanced Macrophage Migration in Diabetes Mellitus by Increasing Expression of Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4</title><author>Tan, Chunyan ; Day, Robert ; Bao, Shunzhong ; Turk, John ; Zhao, Qingwei David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1713-3738729a0aa02e12c2f0417bdae105d417bec6e88752d9bd2033faab0ae8528d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Atherosclerosis - enzymology</topic><topic>Atherosclerosis - genetics</topic><topic>Atherosclerosis - immunology</topic><topic>Atherosclerosis - pathology</topic><topic>Cell Movement</topic><topic>Cells, Cultured</topic><topic>Diabetes Mellitus - enzymology</topic><topic>Diabetes Mellitus - genetics</topic><topic>Diabetes Mellitus - immunology</topic><topic>Diabetes Mellitus - pathology</topic><topic>Diet, High-Fat</topic><topic>Disease Models, Animal</topic><topic>Disease Progression</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Group VI Phospholipases A2 - genetics</topic><topic>Group VI Phospholipases A2 - metabolism</topic><topic>Hydrogen Peroxide - metabolism</topic><topic>Lysophospholipids - metabolism</topic><topic>Macrophages, Peritoneal - enzymology</topic><topic>Macrophages, Peritoneal - immunology</topic><topic>Macrophages, Peritoneal - pathology</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>NADPH Oxidase 4</topic><topic>NADPH Oxidases - genetics</topic><topic>NADPH Oxidases - metabolism</topic><topic>Oligonucleotides, Antisense - metabolism</topic><topic>Receptors, LDL - deficiency</topic><topic>Receptors, LDL - genetics</topic><topic>Signal Transduction</topic><topic>Stress, Physiological</topic><topic>Time Factors</topic><topic>Transfection</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tan, Chunyan</creatorcontrib><creatorcontrib>Day, Robert</creatorcontrib><creatorcontrib>Bao, Shunzhong</creatorcontrib><creatorcontrib>Turk, John</creatorcontrib><creatorcontrib>Zhao, Qingwei David</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tan, Chunyan</au><au>Day, Robert</au><au>Bao, Shunzhong</au><au>Turk, John</au><au>Zhao, Qingwei David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Group VIA Phospholipase A2 Mediates Enhanced Macrophage Migration in Diabetes Mellitus by Increasing Expression of Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4</atitle><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle><addtitle>Arterioscler Thromb Vasc Biol</addtitle><date>2014-04</date><risdate>2014</risdate><volume>34</volume><issue>4</issue><spage>768</spage><epage>778</epage><pages>768-778</pages><issn>1079-5642</issn><eissn>1524-4636</eissn><abstract>OBJECTIVE—We previously demonstrated that nicotinamide adenine dinucleotide phosphate oxidase 4 (Nox4) mediates increased monocyte priming and chemotaxis under conditions of diabetic metabolic stress, and emerging data indicate that group VIA phospholipase A2 (iPLA2β) also participates in regulating monocyte chemotaxis. Here, we examined relationships between iPLA2β expression and Nox4 action in mouse peritoneal macrophages subjected to diabetic metabolic stress. APPROACH AND RESULTS—Increased iPLA2β expression and activity were observed in macrophages from low-density lipoprotein receptor knockout mice that were fed a high-fat diet, and this was associated with time-dependent increases in atherosclerotic lesion size and macrophage content. Incubating macrophages with 30 mmol/L D-glucose, 100 μg/mL low-density lipoprotein, or both (D-glucose+low-density lipoprotein) induced a robust increase in iPLA2β expression and activity and in cell migration in response to monocyte chemoattractant protein-1. The increases in iPLA2β activity and cell migration were prevented by a bromoenol lactone iPLA2β suicide inhibitor or an iPLA2β antisense oligonucleotide. Incubating macrophages under conditions that mimic diabetic metabolic stress ex vivo resulted in increased Nox4 expression and activity and hydrogen peroxide generation compared with controls. Bromoenol lactone prevented those effects without affecting Nox2 expression. Nox4 inhibition eliminated diabetic metabolic stress–induced acceleration of macrophage migration. Lysophosphatidic acid restored Nox4 expression, hydrogen peroxide generation, and migration to bromoenol lactone–treated cells, and a lysophosphatidic acid receptor antagonist abrogated iPLA2β-mediated increases in Nox4 expression. CONCLUSIONS—Taken together, these observations identify iPLA2β and lysophosphatidic acid derived from its action as critical in regulating macrophage Nox4 activity and migration in the diabetic state in vivo and under similar conditions ex vivo.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>24482376</pmid><doi>10.1161/ATVBAHA.113.302847</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1079-5642
ispartof Arteriosclerosis, thrombosis, and vascular biology, 2014-04, Vol.34 (4), p.768-778
issn 1079-5642
1524-4636
language eng
recordid cdi_pubmed_primary_24482376
source MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection
subjects Animals
Atherosclerosis - enzymology
Atherosclerosis - genetics
Atherosclerosis - immunology
Atherosclerosis - pathology
Cell Movement
Cells, Cultured
Diabetes Mellitus - enzymology
Diabetes Mellitus - genetics
Diabetes Mellitus - immunology
Diabetes Mellitus - pathology
Diet, High-Fat
Disease Models, Animal
Disease Progression
Enzyme Inhibitors - pharmacology
Group VI Phospholipases A2 - genetics
Group VI Phospholipases A2 - metabolism
Hydrogen Peroxide - metabolism
Lysophospholipids - metabolism
Macrophages, Peritoneal - enzymology
Macrophages, Peritoneal - immunology
Macrophages, Peritoneal - pathology
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
NADPH Oxidase 4
NADPH Oxidases - genetics
NADPH Oxidases - metabolism
Oligonucleotides, Antisense - metabolism
Receptors, LDL - deficiency
Receptors, LDL - genetics
Signal Transduction
Stress, Physiological
Time Factors
Transfection
Up-Regulation
title Group VIA Phospholipase A2 Mediates Enhanced Macrophage Migration in Diabetes Mellitus by Increasing Expression of Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T20%3A53%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_wolte&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Group%20VIA%20Phospholipase%20A2%20Mediates%20Enhanced%20Macrophage%20Migration%20in%20Diabetes%20Mellitus%20by%20Increasing%20Expression%20of%20Nicotinamide%20Adenine%20Dinucleotide%20Phosphate%20Oxidase%204&rft.jtitle=Arteriosclerosis,%20thrombosis,%20and%20vascular%20biology&rft.au=Tan,%20Chunyan&rft.date=2014-04&rft.volume=34&rft.issue=4&rft.spage=768&rft.epage=778&rft.pages=768-778&rft.issn=1079-5642&rft.eissn=1524-4636&rft_id=info:doi/10.1161/ATVBAHA.113.302847&rft_dat=%3Cpubmed_wolte%3E24482376%3C/pubmed_wolte%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/24482376&rfr_iscdi=true